Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study Evaluating 68Ga-FAPI-46 Tumor Microenvironment Interaction in Solid Tumor Patients

NCT06922825 is registered in ClinicalTrials.gov with Eben Rosenthal as lead sponsor.

NCT NCT06922825
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06922825 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study Evaluating 68Ga-FAPI-46 Tumor Microenvironment Interaction in Solid Tumor Patients
Lead sponsor
Eben Rosenthal
Phase
Phase 1
Overall status
Withdrawn
Start date
January 31, 2027
Completion date
September 30, 2032
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, malignancy, solid tumor cancer, solid tumor malignancy